SAN MATEO, CA -- (MARKET WIRE) -- September 18, 2006 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York. Friedhelm Blobel, Ph.D., SciClone’s President and Chief Executive Officer, will deliver a corporate overview presentation on Monday, September 25, 2006 at 9:30 am EDT.
